Literature DB >> 21084762

Involvement of the immune system in idiosyncratic drug reactions.

Xiaochu Zhang1, Xiachu Zhang, Feng Liu, Xin Chen, Xu Zhu, Jack Uetrecht.   

Abstract

There is strong evidence that most idiosyncratic drug reactions (IDRs) are immune-mediated and are caused by reactive metabolites of a drug rather than by the drug itself. Several hypotheses have been proposed by which a drug could induce an immune response. The major hypotheses are the hapten hypothesis and the danger hypothesis; however, the characteristics and spectrum of IDRs are different with different drugs, and this likely reflects mechanistic differences; therefore, no one hypothesis is likely to explain all IDRs. Some IDRs appear to involve epigenetic effects, direct activation of antigen-presenting cells, or disturbing the normal balance of the immune system. It has been suggested that many cases of idiosyncratic liver injury are not immune-mediated, and other mechanisms such as mitochondrial injury may be involved. It is essential that any hypothesis be consistent with the clinical characteristics of the IDR. Although the characteristics of most idiosyncratic liver injury do not suggest that mitochondria are the major target, it is quite possible that milder mitochondrial injury could stimulate an immune-mediated reaction. The observation that IDRs can vary widely among different drugs and different patients is most easily explained by an immune mechanism in which the target of the immune response is different.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21084762     DOI: 10.2133/dmpk.dmpk-10-rv-085

Source DB:  PubMed          Journal:  Drug Metab Pharmacokinet        ISSN: 1347-4367            Impact factor:   3.614


  9 in total

Review 1.  Molecular mechanisms underlying chemical liver injury.

Authors:  Xinsheng Gu; Jose E Manautou
Journal:  Expert Rev Mol Med       Date:  2012-02-03       Impact factor: 5.600

Review 2.  In vitro testing for diagnosis of idiosyncratic adverse drug reactions: Implications for pathophysiology.

Authors:  Abdelbaset A Elzagallaai; Michael J Rieder
Journal:  Br J Clin Pharmacol       Date:  2015-06-01       Impact factor: 4.335

3.  Mechanism of quinine-dependent monoclonal antibody binding to platelet glycoprotein IIb/IIIa.

Authors:  Daniel W Bougie; Julie Peterson; Mark Rasmussen; Richard H Aster
Journal:  Blood       Date:  2015-09-09       Impact factor: 22.113

4.  Tongue swelling in association with oseltamivir (Tamiflu).

Authors:  Tania Kalsi; Jennifer Stevenson; Paul Wade; Mark Kinirons
Journal:  BMJ Case Rep       Date:  2011-08-04

Review 5.  Oxidant stress, mitochondria, and cell death mechanisms in drug-induced liver injury: lessons learned from acetaminophen hepatotoxicity.

Authors:  Hartmut Jaeschke; Mitchell R McGill; Anup Ramachandran
Journal:  Drug Metab Rev       Date:  2012-01-10       Impact factor: 4.518

Review 6.  Therapeutic Potential of MRGPRX2 Inhibitors on Mast Cells.

Authors:  Hiroyuki Ogasawara; Masato Noguchi
Journal:  Cells       Date:  2021-10-27       Impact factor: 6.600

7.  Insulin-induced localized lipoatrophy preceded by shingles (herpes zoster): a case report.

Authors:  Ernst A Chantelau; Ruth Prätor; Jörg Prätor
Journal:  J Med Case Rep       Date:  2014-06-24

8.  Subtoxic Concentrations of Hepatotoxic Drugs Lead to Kupffer Cell Activation in a Human In Vitro Liver Model: An Approach to Study DILI.

Authors:  Victoria Kegel; Elisa Pfeiffer; Britta Burkhardt; Jia L Liu; Katrin Zeilinger; Andreas K Nüssler; Daniel Seehofer; Georg Damm
Journal:  Mediators Inflamm       Date:  2015-09-28       Impact factor: 4.711

Review 9.  T-cell-mediated drug hypersensitivity: immune mechanisms and their clinical relevance.

Authors:  James Yun; Fenfen Cai; Frederick J Lee; Werner J Pichler
Journal:  Asia Pac Allergy       Date:  2016-04-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.